SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022328
Filing Date
2020-05-07
Accepted
2020-05-07 06:31:40
Documents
64
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q krtx-10q_20200331.htm 10-Q 1414882
2 EX-31.1 krtx-ex311_6.htm EX-31.1 9443
3 EX-31.2 krtx-ex312_8.htm EX-31.2 9424
4 EX-32.1 krtx-ex321_7.htm EX-32.1 8500
  Complete submission text file 0001564590-20-022328.txt   5301394

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT krtx-20200331.xml EX-101.INS 993378
6 XBRL TAXONOMY EXTENSION SCHEMA krtx-20200331.xsd EX-101.SCH 48736
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE krtx-20200331_cal.xml EX-101.CAL 55115
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krtx-20200331_def.xml EX-101.DEF 156170
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE krtx-20200331_lab.xml EX-101.LAB 383039
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krtx-20200331_pre.xml EX-101.PRE 292958
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38958 | Film No.: 20854442
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences